604 related articles for article (PubMed ID: 25525743)
21. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
Konduracka E; Galicka-Latala D; Cieslik G; Rostoff P; Fedak D; Sieradzki J; Naskalski J; Piwowarska W
Diabetes Obes Metab; 2008 Sep; 10(9):719-25. PubMed ID: 17941871
[TBL] [Abstract][Full Text] [Related]
22. The effects of treatment with atorvastatin versus rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia.
Demir V; Doğru MT; Ede H; Yilmaz S; Alp C; Celik Y; Yildirim N
Cardiovasc J Afr; 2018 May/Jun 23; 29(3):162-166. PubMed ID: 29528361
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease.
Powell TM; Paul JD; Hill JM; Thompson M; Benjamin M; Rodrigo M; McCoy JP; Read EJ; Khuu HM; Leitman SF; Finkel T; Cannon RO
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):296-301. PubMed ID: 15569821
[TBL] [Abstract][Full Text] [Related]
24. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery.
Chello M; Goffredo C; Patti G; Candura D; Melfi R; Mastrobuoni S; Di Sciascio G; Covino E
Eur J Cardiothorac Surg; 2005 Dec; 28(6):805-10. PubMed ID: 16274999
[TBL] [Abstract][Full Text] [Related]
25. Atorvastatin normalizes endothelial function in healthy smokers.
Agewall S; Hernberg A
Clin Sci (Lond); 2006 Jul; 111(1):87-91. PubMed ID: 16608440
[TBL] [Abstract][Full Text] [Related]
26. Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling.
Calò LA; Facco M; Davis PA; Pagnin E; Maso LD; Puato M; Caielli P; Agostini C; Pessina AC
Hypertens Res; 2011 Sep; 34(9):1017-22. PubMed ID: 21654754
[TBL] [Abstract][Full Text] [Related]
27. Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans.
Wouters CW; Wever KE; Bronckers I; Hopman MT; Smits P; Thijssen DH; Rongen GA
J Cardiovasc Pharmacol; 2012 Jan; 59(1):22-8. PubMed ID: 21885990
[TBL] [Abstract][Full Text] [Related]
28. Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress.
Tousoulis D; Andreou I; Tsiatas M; Miliou A; Tentolouris C; Siasos G; Papageorgiou N; Papadimitriou CA; Dimopoulos MA; Stefanadis C
Atherosclerosis; 2011 Jan; 214(1):151-7. PubMed ID: 21122851
[TBL] [Abstract][Full Text] [Related]
29. Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure.
Young JM; Strey CH; George PM; Florkowski CM; Sies CW; Frampton CM; Scott RS
Eur J Heart Fail; 2008 May; 10(5):463-6. PubMed ID: 18430606
[TBL] [Abstract][Full Text] [Related]
30. Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells.
Chiang KH; Cheng WL; Shih CM; Lin YW; Tsao NW; Kao YT; Lin CT; Wu SC; Huang CY; Lin FY
PLoS One; 2015; 10(8):e0136405. PubMed ID: 26309120
[TBL] [Abstract][Full Text] [Related]
31. Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.
Liu B; Cao HM; Li GY; Liu M; Feng J; Li J; Wang Q
J Int Med Res; 2011; 39(6):2314-22. PubMed ID: 22289549
[TBL] [Abstract][Full Text] [Related]
32. Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure.
Tousoulis D; Antoniades C; Vassiliadou C; Toutouza M; Pitsavos C; Tentolouris C; Trikas A; Stefanadis C
Eur J Heart Fail; 2005 Dec; 7(7):1126-32. PubMed ID: 16051518
[TBL] [Abstract][Full Text] [Related]
33. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
Dogra G; Irish A; Chan D; Watts G
Am J Kidney Dis; 2007 Jun; 49(6):776-85. PubMed ID: 17533020
[TBL] [Abstract][Full Text] [Related]
35. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.
Mozaffarian D; Minami E; Letterer RA; Lawler RL; McDonald GB; Levy WC
Am J Cardiol; 2005 Dec; 96(12):1699-704. PubMed ID: 16360360
[TBL] [Abstract][Full Text] [Related]
36. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
Prasad A; Gössl M; Hoyt J; Lennon RJ; Polk L; Simari R; Holmes DR; Rihal CS; Lerman A
Catheter Cardiovasc Interv; 2013 May; 81(6):930-6. PubMed ID: 22517646
[TBL] [Abstract][Full Text] [Related]
37. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
[TBL] [Abstract][Full Text] [Related]
38. Impaired progenitor cell activity in age-related endothelial dysfunction.
Heiss C; Keymel S; Niesler U; Ziemann J; Kelm M; Kalka C
J Am Coll Cardiol; 2005 May; 45(9):1441-8. PubMed ID: 15862416
[TBL] [Abstract][Full Text] [Related]
39. High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period.
Ye H; He F; Fei X; Lou Y; Wang S; Yang R; Hu Y; Chen X
J Cardiovasc Pharmacol Ther; 2014 May; 19(3):290-5. PubMed ID: 24346155
[TBL] [Abstract][Full Text] [Related]
40. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure.
Valgimigli M; Rigolin GM; Fucili A; Porta MD; Soukhomovskaia O; Malagutti P; Bugli AM; Bragotti LZ; Francolini G; Mauro E; Castoldi G; Ferrari R
Circulation; 2004 Sep; 110(10):1209-12. PubMed ID: 15249502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
